Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibodies with a broad spectrum of neutralizing activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Favorskaya, Irina A., Shcheblyakov, Dmitry V., Esmagambetov, Ilias B., Dolzhikova, Inna V., Alekseeva, Irina A., Korobkova, Anastasia I., Voronina, Daria V., Ryabova, Ekaterina I., Derkaev, Artem A., Kovyrshina, Anna V., Iliukhina, Anna A., Botikov, Andrey G., Voronina, Olga L., Egorova, Daria A., Zubkova, Olga V., Ryzhova, Natalia N., Aksenova, Ekaterina I., Kunda, Marina S., Logunov, Denis Y., Naroditsky, Boris S., Gintsburg, Alexandr L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907979/
https://www.ncbi.nlm.nih.gov/pubmed/35281053
http://dx.doi.org/10.3389/fimmu.2022.822159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907979/
https://www.ncbi.nlm.nih.gov/pubmed/35281053
http://dx.doi.org/10.3389/fimmu.2022.822159

Ejemplares similares